PEMAZYRE FDA approval date
The FDA approved PEMAZYRE on 17 Apr 2020.
- FDA approval date
- 17 Apr 2020
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as PEMIGATINIB
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2020-04-17Day | PEMAZYRE | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA213736", "applicant_as_listed_by_fda": "INCYTE CORP", "brand_names": ["PEMAZYRE"], "active_ingredients": ["PEMIGATINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200417", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |